Pulse Oximeter Accuracy: What the ±2% Figure Means and What Disturbs It
SpO2 Sensor Factory Editorial Team · 21 October 2026
Pulse oximetry is one of the most frequently used measurements in acute care, and one of the most frequently misunderstood. The number on the screen looks precise, but it is a statistical estimate derived from a ratio of light absorption, and its stated accuracy applies only under defined conditions. For biomedical engineers specifying accessories, clinical educators teaching staff, and distributors supporting hospital customers, understanding what the ±2% figure actually covers — and what undermines it — is essential to safe use.
How accuracy is specified
Pulse oximeter accuracy is conventionally expressed as the root-mean-square deviation (RMSD or Arms) between the device's reading and a reference measurement, almost always arterial blood gas co-oximetry, in a controlled desaturation study performed on healthy adult volunteers. The commonly quoted figure is ±2%, but the detail that matters is the range over which it applies: typically 70–100% SpO2. Within that range, the value has been characterised against a reference standard.
Below approximately 70%, readings are extrapolated from the calibration curve rather than validated by direct measurement. Ethics and safety constraints make it difficult to gather reference data at profound hypoxaemia in volunteers, so treat readings in this region as directional rather than quantitative. The same caution applies to patient groups excluded from or underrepresented in validation studies — for example, patients with poor perfusion or significant dyshaemoglobinaemia. This context is worth rehearsing with clinical staff: the ±2% figure is a statement about a calibration range and a study population, not a universal guarantee for every patient at every moment.
Understanding the measurement principle itself helps explain the failure modes below. For a refresher suitable for clinical education, see our explanation of how a pulse oximeter works.
Motion artefact
The most common real-world disturber of pulse oximeter accuracy is patient motion. The technology separates the pulsatile (arterial) component of light absorption from the non-pulsatile (venous, capillary, tissue) component by detecting a periodic signal synchronous with the heartbeat. Movement introduces optical and mechanical noise across a broad frequency range that overlaps with the pulse rate, so the algorithm may misidentify noise as pulsatility, fail to identify a pulse at all, or report values that drift while the display still looks plausible.
Motion artefact is not limited to shivering or seizure activity. Routine procedures — repositioning, airway management, transport, physiotherapy, blood draws — can disturb a poorly secured sensor. Practical mitigations include:
- Choosing a sensor format suited to the patient's activity level; adhesive and wrap styles generally tolerate movement better than a finger clip.
- Securing the cable so it does not tug on the sensor, and routing it to allow movement without displacing the emitter–detector pair.
- Treating a reading that changes abruptly during handling with suspicion until the patient has been observed and the signal has settled.
- Being aware that some monitors display a signal-quality or pulse-detection indicator; a reading should not be accepted when that indicator is poor, regardless of how reasonable the number appears.
For educators, motion artefact is a useful teaching case because it demonstrates the difference between a value being displayed and a value being trustworthy.
Low perfusion and signal quality indicators
Pulse oximetry depends on a detectable arterial pulse at the sensor site. When perfusion is reduced — cold peripheries, vasoconstriction, hypotension, shock, or the effects of vasoactive medication — the pulsatile component becomes small relative to noise, and the ratio the device relies on becomes less reliable. Readings may be erratic, delayed, or simply unavailable.
Clinically this matters most in the very patients who most need accurate monitoring. A common practical response is to move the sensor to a site with better perfusion — a different finger, a toe, the ear lobe, or another site supported by the sensor range — and to warm the extremity if appropriate. Each site has its own characteristics, and no single site is universally superior. Some monitors expose a plethysmographic waveform or perfusion indicator; a weak or irregular waveform is a warning about the reading, not a decoration. This is also why environmental conditions matter: cold ambient temperatures in transport vehicles or procedure rooms can degrade peripheral signal before any clinical deterioration occurs.
Sensor fit and placement
A pulse oximeter sensor is an optical assembly with specific geometry. The emitter and detector must be aligned across the tissue bed, the light path must not be short-circuited by ambient light, and the tissue must be neither so thick that signal is lost nor so thin that light reaches the detector without passing through arterial blood. Correct size selection for the patient range is a manufacturer specification, which is why sensor formats — finger clip, silicone soft tip, wrap, and adhesive disposable sensors — are offered in distinct sizes rather than as one-size-fits-all devices.
Common fit and placement errors
- Wrong size: an oversized sensor on a small finger allows ambient light to reach the detector and can shift the emitter–detector geometry; an undersized sensor may not transmit enough light.
- Partial placement: a sensor positioned at an angle, or not fully seated over the nail bed on a finger clip, produces uneven tissue illumination.
- Ambient light leakage: bright overhead lighting, surgical lights, and sunlight can enter the sensor path and offset the detected signal. Repositioning the sensor, shading the site, or using a better-fitting sensor usually resolves this.
- Displacement over time: a sensor that was correctly placed can migrate, especially with adhesive sensors that lift at the edges or reusable sensors held only by a clip on an oedematous finger.
- Site condition: excessive motion at the site, nail polish (see below), oedema, or local skin changes can each affect signal quality.
For reusable formats — commonly used in wards, clinics, and transport — durability and correct sizing across the patient range are the practical selection criteria. Our reusable SpO2 sensors are offered to match monitor compatibility and patient range requirements.
Nail products and artificial nails
Nail polish, gel coatings, acrylics, and other nail products sit directly in the optical path of a finger sensor. Their effect on pulse oximeter accuracy varies by product type, colour, and thickness, and the published evidence is genuinely mixed: some products and shades have little measurable effect, while others are reported to interfere with readings in some studies. It is not possible to state a single reliable rule that covers all products, and we would not attempt to.
The practical guidance is straightforward: if a reading is unexpected, discordant with the clinical picture, or the signal quality is poor, remove nail product or move the sensor to an unadorned digit, and reassess. Do not assume that dark polish is always problematic or that clear polish is always fine. For clinical educators, this is a good example of the principle "treat the reading as a question, not an answer."
Dyshaemoglobins: carboxyhaemoglobin and methaemoglobin
Conventional pulse oximeters use two wavelengths of light (typically red and infrared) and infer oxygen saturation from their relative absorption. This design cannot reliably distinguish oxyhaemoglobin from two other haemoglobin species that absorb light at similar wavelengths.
Carboxyhaemoglobin
Carboxyhaemoglobin (COHb), formed in carbon monoxide exposure, has an absorption spectrum that overlaps with oxyhaemoglobin at the wavelengths used by standard two-wavelength oximetry. The result is that the device may report a normal or near-normal SpO2 even when a substantial proportion of haemoglobin is bound to carbon monoxide and oxygen delivery is impaired. The reading is not a measure of oxygen content. This is a well-established limitation and a standard teaching point in toxicology and emergency care; a normal SpO2 does not exclude carbon monoxide poisoning, and diagnosis requires co-oximetry (typically on arterial or venous blood gas) and clinical assessment.
Methaemoglobin
Methaemoglobin (MetHb) is haemoglobin in which iron is oxidised to the ferric state and cannot bind oxygen reversibly. It has characteristic absorption that, at the two standard wavelengths, can push the calculated saturation toward a fixed intermediate value. A classic teaching sign is a reading that plateaus around the mid-80s and does not respond to supplemental oxygen, in a patient who may appear cyanotic despite a reassuring-looking number. As with COHb, definitive identification requires multi-wavelength co-oximetry; pulse oximetry alone cannot quantify dyshaemoglobins.
For both species, the clinical response is the same: when the oximeter reading conflicts with the patient's appearance or clinical trajectory, escalate to blood gas analysis where indicated rather than adjusting oxygen therapy on the number alone.
Skin pigmentation
Regulators and researchers have studied pulse oximeter performance differences across skin tones, and the topic is now a recognised patient-safety issue in clinical practice and device standards. The mechanism is optical: melanin absorbs light across the visible and near-infrared spectrum, and greater epidermal pigmentation can reduce the signal-to-noise ratio at the detector, making readings more vulnerable to the error sources already described — poor perfusion, motion, and suboptimal fit.
We will not quantify the effect here, because reliable quantification depends on device, population, and study design, and inventing figures would be irresponsible. What we can state factually is the practical response:
- Correct sizing and fit: a sensor that matches the patient's anatomy and sits correctly on the site is the first line of defence against signal loss.
- Careful placement: verify full seating, alignment, and shielding from ambient light.
- Awareness of occult hypoxaemia: clinicians should know that a normal-looking SpO2 can mask hypoxaemia in some patients, and that trends, symptoms, and other clinical signs should be weighed alongside the reading. Where concern exists, arterial blood gas measurement provides direct confirmation.
For distributors, this is a topic worth including in customer training materials and in conversations about sensor selection across patient populations.
Intravenous dyes and bright ambient light
Certain intravenous dyes used in diagnostic procedures can transiently affect optical measurements, and very bright ambient light — surgical lighting, direct sunlight, examination lamps — can leak into the sensor path and disturb the reading. Both effects are usually short-lived or correctable by repositioning and shading the sensor, but they belong on the list of reasons an isolated unexpected value should be rechecked rather than acted on immediately.
A practical accuracy checklist for clinical areas
The following checklist summarises the practical responses covered above. It is written for bedside use and for incorporation into competency training.
- Match the sensor to the patient: correct format and size for the patient range, per manufacturer specification.
- Verify placement: fully seated, aligned, and shielded from ambient light; cable secured without tension.
- Check signal quality: where the monitor provides a waveform, perfusion, or quality indicator, confirm it is adequate before accepting the value.
- Consider perfusion: cold or poorly perfused extremities may warrant a different site or warming; do not accept a reading from a clearly inadequate signal.
- Remove obstructions: nail products, dirt, or moisture in the optical path should be addressed if the reading is unexpected.
- Suspect dyshaemoglobins when the reading conflicts with the clinical picture, particularly a plateau that does not respond to oxygen; confirm with co-oximetry where indicated.
- Account for skin pigmentation as a factor in signal quality and occult hypoxaemia risk; rely on clinical assessment and blood gas measurement when concerned.
- Recheck before acting: an unexpected value should prompt observation of the patient and, where indicated, arterial blood gas measurement — not an immediate change in therapy based on the number alone.
Pulse oximeter accuracy is best understood as a conditional property. The ±2% figure describes performance within a validated range and population; the conditions of real clinical use — motion, perfusion, fit, nail products, dyshaemoglobins, pigmentation, dyes, and light — determine whether that performance is realised for a given patient at a given moment. Designing accessory selection and clinical training around those conditions is a practical way to support safer monitoring.
When to distrust the number: a bedside routine
Experienced clinicians run the same short routine when a reading surprises them. One: look at the patient, not the screen — colour, work of breathing and consciousness outrank any single value. Two: check the signal — waveform quality, perfusion indicator, and whether the oximeter's pulse rate agrees with the ECG or a palpated pulse; disagreement means artefact until proven otherwise. Three: check the sensor — right size, right site, aligned optics, no ambient-light leak, cable undamaged; reposition or swap the sensor (a known-good reusable sensor is the fastest test instrument on the ward). Four: consider the physiology that fools two-wavelength oximetry — carbon monoxide exposure, methaemoglobinaemia, severe anaemia — and escalate to arterial blood gas with co-oximetry when the clinical picture and the number refuse to agree. The routine takes under a minute, and it converts most "monitor problems" into either a fixed sensor or an appropriately escalated patient.
Educational overview. A pulse oximeter reading is one input among many; unexpected values should be checked against the patient and, where indicated, arterial blood gas measurement.